Certain chemotherapy drugs can be used after the first trimester. Other therapies—including HER2-targeted drugs—are normally postponed until after delivery. Radiation is generally delayed. Treatment is coordinated among oncology, obstetric and neonatal teams.
Rapplean's timeline reflects that kind of sequencing.
Chemotherapy that could be administered during late pregnancy came first.
Delivery followed.
Treatments unsuitable for pregnancy could then begin.
The story was not medicine choosing one life over another.
It was medicine trying to protect both while confronting an aggressive disease that could not simply wait.
Strength Is Not the Absence of Fear
Stories about cancer survivors are often simplified into narratives about “fighting” and “being strong.”
Those words can be meaningful.
But they can also create an unrealistic picture.
Strength does not mean a patient never feels terrified.
It does not mean every appointment is approached with confidence.
It does not guarantee a particular outcome.
Cancer biology does not respond to courage alone.
Treatment, tumor characteristics, medical expertise, access to care and sometimes unpredictable biological factors all matter.
What courage can influence is the decision to keep participating in the process.
One more appointment.
One more infusion.
One more scan.
One more surgery.
Another morning of getting out of bed when the future feels uncertain.
Rapplean herself described her motivation in terms that had very little to do with heroic imagery.
She wanted bedtime stories.
Birthday parties.
Milestones.
Hugs.
She wanted decades with her children.
Those ordinary ambitions became her reasons to endure extraordinary circumstances.
More Than Two Years Later
In February 2024, Kiersten Rapplean was 29 weeks pregnant and facing an aggressive cancer diagnosis.
On March 25, she gave birth to Travis.
Three days later, she was already moving into another phase of cancer treatment.
By June, she had completed five rounds of TCHP.
In July, she underwent a double mastectomy.
Treatment and follow-up continued.
Then came July 2026.
The woman who had once written publicly about the unbearable possibility of missing her children's future was now appearing in local news coverage associated with a very different message:
She was still here.
Her baby had become a growing little boy.
And the latest public reporting described her as cancer-free.
The medical story is not necessarily finished.
Stage IV cancer demands humility about words such as “cure,” and only Rapplean and her medical team know the complete details of her current disease status and treatment plan.
But neither should that uncertainty overshadow what had already happened.
She went from receiving chemotherapy while pregnant to delivering a son.
From postpartum recovery to targeted treatment in a matter of days.
From repeated chemotherapy to major surgery.
From confronting a Stage IV diagnosis to living long enough to see medicine achieve what, at the beginning, she could only hope for.
Her story is not proof that determination alone defeats cancer.
It is something more truthful.
It is a story about what determination looks like while medicine does its work.
A mother entering another treatment room.
A family caring for a newborn while fearing for his mother's future.
Doctors trying to balance an aggressive disease with a pregnancy.
A baby spending 17 days in intensive care and eventually going home.
A woman continuing treatment because she wants to see the next birthday.
Then the birthday after that.
And the one after that.
For Kiersten Rapplean, the future was never an abstract idea.
It had names.
Emmett.
Travis.
Her family.
And all the ordinary days she refused to stop hoping she would be there to see.
Sources
Kiersten Rapplean's personal GoFundMe account, launched September 9, 2024. Primary-source account of her diagnosis, pregnancy, Travis' birth, NICU stay and 2024 treatment timeline, including AC chemotherapy, TCHP and double mastectomy.
KSDK / 5 On Your Side, July 29, 2026. Missouri local-news reporting describing Rapplean as cancer-free while covering the expansion of the SSM Health St. Joseph Hospital Cancer Center.
National Cancer Institute — Breast Cancer During Pregnancy. Medical guidance on pregnancy-associated breast cancer, treatment timing and the use of chemotherapy during pregnancy.
National Cancer Institute — Inflammatory Breast Cancer. Information on the rarity, biology, staging and aggressive nature of inflammatory breast cancer.
American Cancer Society — Treating Breast Cancer During Pregnancy. Guidance regarding chemotherapy during the second and third trimesters and the postponement of HER2-targeted therapy until after pregnancy.
American Cancer Society — Targeted Therapy for Breast Cancer. Information about HER2-positive disease and drugs including trastuzumab and pertuzumab.
American Cancer Society — Treatment of Stage IV Breast Cancer. Current guidance explaining the role of long-term systemic therapy and why metastatic breast cancer is generally considered difficult to cure even after major treatment responses.
SSM Health, July 9, 2026. Official announcement detailing the multimillion-dollar expansion of the cancer center at SSM Health St. Joseph Hospital – Lake Saint Louis.